000 | 00914 a2200277 4500 | ||
---|---|---|---|
005 | 20250513114153.0 | ||
264 | 0 | _c19970617 | |
008 | 199706s 0 0 eng d | ||
022 | _a1071-9091 | ||
024 | 7 |
_a10.1016/s1071-9091(97)80003-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBourgeois, B F | |
245 | 0 | 0 |
_aFelbamate. _h[electronic resource] |
260 |
_bSeminars in pediatric neurology _cMar 1997 |
||
300 |
_a3-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnticonvulsants _xadverse effects |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aEpilepsy _xdrug therapy |
650 | 0 | 4 | _aFelbamate |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPhenylcarbamates |
650 | 0 | 4 |
_aPropylene Glycols _xadverse effects |
773 | 0 |
_tSeminars in pediatric neurology _gvol. 4 _gno. 1 _gp. 3-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1071-9091(97)80003-4 _zAvailable from publisher's website |
999 |
_c9080116 _d9080116 |